Talkspace (NASDAQ: TALK) CTO has 495K options canceled in merger
Rhea-AI Filing Summary
Talkspace, Inc. (TALK) reports that Chief Technology Officer Gil Margolin disposed of common stock and stock options in connection with the closing of a merger under a March 9, 2026 Merger Agreement with Universal Health Services, Inc. and its merger subsidiary. At the effective time, 106,387 shares of Talkspace common stock were converted into the right to receive $5.25 in cash per share, and additional equity awards were converted or canceled pursuant to the agreement terms. Vested stock options with exercise prices below $5.25 were canceled in exchange for a cash payment based on the spread between the Merger Consideration and the option exercise price, while certain vested options with a $5.81 exercise price were canceled for no consideration. Unvested RSUs and unvested options were assumed by Universal Health Services and converted into awards and options over its Class B common stock using an exchange ratio based on the relative closing prices of Talkspace and Universal Health Services shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Options F1, F4 | 7,033 | -- | -- |
| Disposition | Stock Options F1, F4 | 17,088 | -- | -- |
| Disposition | Stock Options F1, F4 | 8,086 | -- | -- |
| Disposition | Stock Options F1, F4 | 15,411 | -- | -- |
| Disposition | Stock Options F1, F5 | 10,549 | -- | -- |
| Disposition | Stock Options F1, F5 | 17,791 | -- | -- |
| Disposition | Stock Options F1, F5 | 11,988 | -- | -- |
| Disposition | Stock Options F1, F6 | 495,000 | -- | -- |
| Disposition | Common Stock F1, F2 | 106,387 | -- | -- |
| Disposition | Common Stock F1, F3 | 160,626 | -- | -- |
Footnotes (6)
- F1. In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time").
- F2. Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration").
- F3. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit (an "RSU") outstanding immediately prior to the Effective Time that remains unvested at the Effective Time was assumed by Parent and converted into a Parent restricted stock unit award relating to a number of shares of Class B Common Stock, par value $0.01 per share, of Parent ("Parent Class B Shares") equal to the product of (i) the number of shares of Common Stock underlying such RSU, multiplied by (ii) a fraction (a) the numerator of which was the closing price of Common Stock on Nasdaq on the last day on which Common Stock was traded on Nasdaq that is immediately prior to the date of the Effective Time and (b) the denominator of which was the closing price of a Parent Class B Share on the New York Stock Exchange on the last day on which Common Stock was traded on Nasdaq that is immediately prior to the date of the Effective Time (the "Exchange Ratio").
- F4. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option.
- F5. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option outstanding and unexercised immediately prior to the Effective Time that is not a Vested Stock Option was assumed by Parent and converted into an option to purchase Parent Class B Shares (each, an "Assumed Option"), with (i) the number of Parent Class B Shares subject to such Assumed Option equal to the product of (a) the number of shares of Common Stock that were issuable upon exercise of the Issuer stock option immediately prior to the Effective Time multiplied by (b) the Exchange Ratio and (ii) a per share exercise price equal to (a) the per share exercise price of the corresponding Issuer stock option divided by (b) the Exchange Ratio.
- F6. Pursuant to the terms of the Merger Agreement, at the Effective Time, each Vested Stock Option reported in this row had an exercise price equal to or greater than the Merger Consideration and was canceled for no consideration.
Key Figures
Key Terms
Merger Consideration financial
Exchange Ratio financial
Vested Stock Option financial
Assumed Option financial
restricted stock unit financial
FAQ
What insider transactions did TALK Chief Technology Officer Gil Margolin report on this Form 4?
How were TALK restricted stock units (RSUs) treated in the Universal Health Services merger?
What happened to TALK vested stock options with exercise prices below the $5.25 Merger Consideration?
How were TALK vested stock options with a $5.81 exercise price treated in the merger?
What happened to unvested TALK stock options after the merger with Universal Health Services?
Was this TALK Form 4 transaction executed under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.